Lyka Labs Hits New 52-Week Low at Rs. 90 Amid Market Struggles
Lyka Labs has hit a new 52-week low, reflecting a significant decline in stock performance and underperformance compared to its sector. Over the past year, the company has faced a substantial drop in profitability and sales, despite maintaining high management efficiency and long-term growth potential. Concerns persist due to a high debt-to-equity ratio.
Lyka Labs, a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs. 90 today, marking a significant downturn in its stock performance. This decline comes as the company has underperformed the sector by 0.68% on the same day. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a persistent downward trend.Over the past year, Lyka Labs has seen a substantial decline of 34.16%, contrasting sharply with the Sensex, which has gained 8.60% during the same period. The company's financial metrics reveal a challenging landscape, with a reported PAT of Rs -3.36 crore, reflecting a drastic fall of 260%. Additionally, net sales have decreased by 10.93%, and the PBDIT has reached a low of Rs -2.54 crore.
Despite these challenges, Lyka Labs maintains a high management efficiency with a ROCE of 17.59% and has shown healthy long-term growth potential, with operating profit increasing at an annual rate of 33.02%. However, the high debt-to-equity ratio of 2.75 times raises concerns about its financial stability.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
